These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 16020115)
21. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166 [TBL] [Abstract][Full Text] [Related]
22. Relative osteopenia after treatment for acute lymphoblastic leukemia. Warner JT; Evans WD; Webb DK; Bell W; Gregory JW Pediatr Res; 1999 Apr; 45(4 Pt 1):544-51. PubMed ID: 10203147 [TBL] [Abstract][Full Text] [Related]
23. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080 [TBL] [Abstract][Full Text] [Related]
24. Bone mineral density in children with myelomeningocele. Apkon SD; Fenton L; Coll JR Dev Med Child Neurol; 2009 Jan; 51(1):63-7. PubMed ID: 18811711 [TBL] [Abstract][Full Text] [Related]
25. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms. Guo CY; Halton JM; Barr RD; Atkinson SA Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924 [TBL] [Abstract][Full Text] [Related]
26. Bone mineral density of both genders in Type 1 diabetes according to bone composition. Hadjidakis DJ; Raptis AE; Sfakianakis M; Mylonakis A; Raptis SA J Diabetes Complications; 2006; 20(5):302-7. PubMed ID: 16949517 [TBL] [Abstract][Full Text] [Related]
27. Effects of thalassemia major on bone mineral density in late adolescence. Benigno V; Bertelloni S; Baroncelli GI; Bertacca L; Di Peri S; Cuccia L; Borsellino Z; Maggio MC J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():337-42. PubMed ID: 12729413 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. King W; Levin R; Schmidt R; Oestreich A; Heubi JE Dev Med Child Neurol; 2003 Jan; 45(1):12-6. PubMed ID: 12549750 [TBL] [Abstract][Full Text] [Related]
29. Inactivity is a risk factor for low bone mineral density among haemophilic children. Tlacuilo-Parra A; Morales-Zambrano R; Tostado-Rabago N; Esparza-Flores MA; Lopez-Guido B; Orozco-Alcala J Br J Haematol; 2008 Mar; 140(5):562-7. PubMed ID: 18275434 [TBL] [Abstract][Full Text] [Related]
30. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454 [TBL] [Abstract][Full Text] [Related]
31. The role of the therapeutic team in shaping eating habits and lifestyle in children with dietary calcium deficiency. Górska A; Konstantynowicz J; Chlabicz S; Urban M; Kaczmarski M Rocz Akad Med Bialymst; 2005; 50 Suppl 1():119-22. PubMed ID: 16119643 [TBL] [Abstract][Full Text] [Related]
32. Little evidence of low bone mass in acute lymphoblastic leukemia survivors. Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524 [TBL] [Abstract][Full Text] [Related]
33. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency. Gonc EN; Kandemir N Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489 [TBL] [Abstract][Full Text] [Related]
34. [Bone mineral density in children before and after completion of cancer treatment]. Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608 [TBL] [Abstract][Full Text] [Related]
35. Bone mineral content deficits of the spine and whole body in children at time of diagnosis with celiac disease. Jatla M; Zemel BS; Bierly P; Verma R J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):175-80. PubMed ID: 19179879 [TBL] [Abstract][Full Text] [Related]
36. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205 [TBL] [Abstract][Full Text] [Related]
37. Low bone mass in children with malignant lymphoma. El-Ziny MA; Al-Tonbary YA; Salama OS; Bakr A; Al-Marsafawy H; Elsharkawy AA Pediatr Hematol Oncol; 2007 Dec; 24(8):577-85. PubMed ID: 18092248 [TBL] [Abstract][Full Text] [Related]
38. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases. Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348 [TBL] [Abstract][Full Text] [Related]
39. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease? Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Chou IJ; Lin KL; Wang HS; Wang CJ Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]